While the direct and immune-mediated antitumor properties of IFN have recently renewed interest in the use of this cytokine in new therapeutic protocols43, HDACi have been reported to induce both cancer cell death and immunomodulatory effects44. This evidence concerns the gene IFNA1 and cancer.